These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19787038)

  • 1. Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal.
    Kazibwe AJ; Nerima B; de Koning HP; Mäser P; Barrett MP; Matovu E
    PLoS Negl Trop Dis; 2009 Sep; 3(9):e523. PubMed ID: 19787038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy.
    Matovu E; Geiser F; Schneider V; Mäser P; Enyaru JC; Kaminsky R; Gallati S; Seebeck T
    Mol Biochem Parasitol; 2001 Sep; 117(1):73-81. PubMed ID: 11551633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutant P2 adenosine transporter (TbAT1) gene in Trypanosoma brucei gambiense isolates from northwest Uganda using allele-specific polymerase chain reaction.
    Nerima B; Matovu E; Lubega GW; Enyaru JC
    Trop Med Int Health; 2007 Nov; 12(11):1361-8. PubMed ID: 18045263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.
    Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
    Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
    Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol.
    Graf FE; Ludin P; Wenzler T; Kaiser M; Brun R; Pyana PP; Büscher P; de Koning HP; Horn D; Mäser P
    PLoS Negl Trop Dis; 2013; 7(10):e2475. PubMed ID: 24130910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
    Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP
    Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein.
    Munday JC; Tagoe DN; Eze AA; Krezdorn JA; Rojas López KE; Alkhaldi AA; McDonald F; Still J; Alzahrani KJ; Settimo L; De Koning HP
    Mol Microbiol; 2015 May; 96(4):887-900. PubMed ID: 25708978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda.
    Priotto G; Fogg C; Balasegaram M; Erphas O; Louga A; Checchi F; Ghabri S; Piola P
    PLoS Clin Trials; 2006 Dec; 1(8):e39. PubMed ID: 17160135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Meta-Analysis on Human African Trypanocide Resistance.
    Kasozi KI; MacLeod ET; Welburn SC
    Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes.
    Stewart ML; Burchmore RJ; Clucas C; Hertz-Fowler C; Brooks K; Tait A; Macleod A; Turner CM; De Koning HP; Wong PE; Barrett MP
    Eukaryot Cell; 2010 Feb; 9(2):336-43. PubMed ID: 19966032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pharmacology of adenosine transport in Trypanosoma brucei: P1/P2 revisited.
    Geiser F; Lüscher A; de Koning HP; Seebeck T; Mäser P
    Mol Pharmacol; 2005 Sep; 68(3):589-95. PubMed ID: 15933219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional expression of TcoAT1 reveals it to be a P1-type nucleoside transporter with no capacity for diminazene uptake.
    Munday JC; Rojas López KE; Eze AA; Delespaux V; Van Den Abbeele J; Rowan T; Barrett MP; Morrison LJ; de Koning HP
    Int J Parasitol Drugs Drug Resist; 2013 Dec; 3():69-76. PubMed ID: 24533295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
    Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness.
    Milord F; Pépin J; Loko L; Ethier L; Mpia B
    Lancet; 1992 Sep; 340(8820):652-5. PubMed ID: 1355219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice.
    Pyana PP; Ngay Lukusa I; Mumba Ngoyi D; Van Reet N; Kaiser M; Karhemere Bin Shamamba S; Büscher P
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1025. PubMed ID: 21526217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei.
    Munday JC; Settimo L; de Koning HP
    Front Pharmacol; 2015; 6():32. PubMed ID: 25814953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.